Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
M.BrownL.AyyappanP.GR
Long-term safety of bremelanotide for hypoactive sexual desire disorder in premenopausal women: findings from a 52-week open-label study
Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products
In the extensive clinical trial programme that led to the medication's approval, changes in sexual function were not identified as a significant adverse event
US$ 27.70
US$ 28.30
US$ 29.45
US$ 25.90
US$ 20.30
US$ 23.69
US$ 24.79
US$ 24.95
US$ 22.05
